- ►annals.org [PDF] DB Badesch, VF Tapson, MD McGoon, BH … - Annals of Internal Medicine, 2000 - Am Coll Physicians David B. Badesch, MD; Victor F. Tapson, MD; Michael D. McGoon, MD; Bruce H.
Brundage, MD; Lewis J. Rubin, MD; Fredrick M. Wigley, MD; Stuart Rich, MD; Robyn
J. Barst, MD; Pamela S. Barrett, PharmD; Kenneth M. Kral, MS; Maria M. ... Cited by 649 - Related articles - BL Direct - All 6 versions
VV McLaughlin, DE Genthner, MM Panella, S … - The New England journal of medicine, 1998 - nejm.highwire.org Results We evaluated 27 patients with primary pulmonary hypertension over a mean
(±SD) period of 16.7±5.2 months. Intravenous adenosine had a variable effect
on pulmonary vascular resistance (mean reduction, 27 percent; range, 0 to ... Cited by 549 - Related articles - BL Direct - All 7 versions
- ►annals.org RJ Barst, LJ Rubin, MD McGoon, EJ Caldwell … - Annals of internal medicine, 1994 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To evaluate the effects of long-term intravenous infusion of ... Cited by 417 - Related articles - All 7 versions
- ►onlinejacc.org N Nagaya, M Uematsu, Y Okano, T Satoh, S … - Journal of the American College of Cardiology, 1999 - Elsevier Twenty-seven patients died of cardiopulmonary causes in the conventional group
during a mean follow-up period of 44 ± 45 months. In contrast, only 4 patients
died of cardiopulmonary causes in the BPS group during a mean follow-up ... Cited by 173 - Related articles - BL Direct - All 11 versions
- ►nih.gov [PDF] A Rozkovec, P Montanes, CM Oakley - British Medical Journal, 1986 - heart.bmj.com Page 1. doi:10.1136/hrt.55.5.449 1986;55;449-458 Heart A Rozkovec, P Montanes
and CM Oakley primary pulmonary hypertension. Factors ... Cited by 118 - Related articles - All 6 versions
- ►nih.gov [PDF] JSR Gibbs, TW Higenbottam, SG Haworth, K … - Heart, 2001 - pubmedcentral.nih.gov Synopsis PRESENTATION AND INVESTIGATION 1. The symptoms of pulmonary
hypertension are relatively non-specific. Breathlessness is the most common. 2.
Where the diagnosis of pulmonary hyper- tension is suspected a ... Cited by 66 - Related articles - Library Search - All 4 versions
FA Burrows, JR Klinck, M Rabinovitch, DJ … - Canadian Journal of Anesthesia/Journal canadien d' …, 1986 - Springer C ontents Introduction Sequelae of pulmonary hypertension - Cardiac function -
Pulmonary function Preoperative assessment of the patient with pulmonary
hypertension - Primary pulmonary vascular occlusive disease - Acyanotic ... Cited by 53 - Related articles - All 3 versions
JC Wanstall, TK Jeffery - Drugs, 1998 - ingentaconnect.com Abstract Pulmonary hypertension (mean pulmonary arterial pressure >20mm Hg at
rest or >30mm Hg during exercise) occurs (i) as primary pulmonary hypertension
(no known underlying cause), (ii) as persistent pulmonary hypertension of ... Cited by 54 - Related articles - BL Direct - All 6 versions
